Treatment approach in patients with hyperbilirubinemia secondary to liver metastases in gastrointestinal malignancies: a case series and review of literature

Treatment approach in patients with hyperbilirubinemia secondary to liver metastases in gastrointestinal malignancies: a case series and review of literature

Background: Treatment of patients with severe liver dysfunction including hyperbilirubinemia secondary to liver metastases of gastrointestinal (GI) cancer is challenging. Regimen of oxaliplatin and fluoropyrimidine (FP)/folinic acid (FA) ± a monoclonal antibody (moAb), represents a feasible option c...

Full description

Bibliographic Details
Main Authors: Julia Quidde, Marc Azémar, Carsten Bokemeyer, Dirk Arnold, Alexander Stein
Format: Article
Language:English
Published: SAGE Publishing 2016-05-01
Series:Therapeutic Advances in Medical Oncology
Online Access:https://doi.org/10.1177/1758834016637585

Internet

https://doi.org/10.1177/1758834016637585

Similar Items